Open AccessAbstract LB-312: Interleukin 6 transsignaling is a candidate mechanism to drive progression of human DCCs during periods of clinical latency
Author(s) -
Melanie Werner-Klein,
Ana Grujovic,
Milan Obradović,
Martin Hoffmann,
Xin Lü,
Stefan Kirsch,
Steffi Treitschke,
Cäcilia Köstler,
Kathrin Weidele,
Christoph Irlbeck,
Catherine Botteron,
Christian Werno,
Bernhard Polzer,
Miodrag Gužvić,
Stefan Buchholz,
Petra Rümmele,
Norbert Heine,
Stefan RoseJohn,
Christoph Klein
Publication year - 2019
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2019-lb-312
Subject(s) - pten , cancer research , stromal cell , bone marrow , biology , breast cancer , metastasis , tumor progression , pi3k/akt/mtor pathway , signal transduction , cancer , immunology , microbiology and biotechnology , genetics